Followers | 821 |
Posts | 31585 |
Boards Moderated | 6 |
Alias Born | 03/22/2016 |
![](https://investorshub.advfn.com/uicon/558887.png?cb=1721046880)
Wednesday, December 21, 2016 1:02:18 PM
Recent BCDA News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 12:00:10 PM
- BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 08/30/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/30/2024 04:15:13 AM
- Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] • Edgar (US Regulatory) • 08/30/2024 12:09:56 AM
- BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family • GlobeNewswire Inc. • 08/29/2024 12:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/29/2024 10:02:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 09:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 11:00:31 AM
- FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 08/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 05:57:35 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/09/2024 08:40:18 PM
- BioCardia to Host Q2 2024 Corporate Update and Financial Results Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 08/02/2024 09:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 11:00:36 AM
- BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 11:00:14 AM
- Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure • GlobeNewswire Inc. • 07/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 11:00:23 AM
- BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:00:39 AM
- CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction • GlobeNewswire Inc. • 07/08/2024 11:00:00 AM
- BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach • GlobeNewswire Inc. • 06/07/2024 11:00:00 AM
- BioCardia Announces Reverse Stock Split • GlobeNewswire Inc. • 05/21/2024 09:00:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM